| Title: | FDA Approval Decisions Report |
| Price: | $125.00 |
| Publication Date: | Jan 01, 2008 |
| Company: | ZymoGenetics, Inc. |
| Report Type: | FDA Approval Decisions Report |
| Abstract: | The Revere FDA Approval Decision Report provides one of the most comprehensive and accurate event calendars for PDUFA dates-expected FDA approval dates for filed drugs. In particular, this report identifies Biotech/Pharmaceutical companies with expected FDA approvals in the next 3 months and reviews all FDA approval decisions in the current month. |
| Brief Excerpt: | ...Some expected PDUFA (Prescription Drug User Fee Act) dates are Revere estimates based on NDA (New Drug Approval) submission dates. Companies are not obligated to disclose NDA submission dates or PDUFA dates, and the FDA may change its approval decision date without prior notice. Drugs developed by private firms or by companies not traded publicly in the U.S. are excluded from this analysis. ... |
| Word Count: | 3421 |
| Length: | 9 Pages |
| Ticker: | ZGEN |
| Exchange: | Nasdaq GM |
| Country: | United States |
| Sector: | Biopharmaceuticals |
| Format: | 
Adobe Acrobat
|
| Free Sample: |
Click
Here
to Download
|
Looking For Something Else?
